Switzerland and the European Union regulate medical devices and in vitro diagnostics under parallel frameworks—MDR and MedDO, IVDR and IvDO—that are technically aligned but institutionally separate.
There is no interface between EUDAMED and swissdamed. There is no single registration number that satisfies both jurisdictions. No single representative can be resident in both. The two systems are twin in substance and divided in structure.
The Structural Risk
For manufacturers of Class C and D devices, this duality is not a bureaucratic inconvenience. It is a structural risk.
Attempting to manage the two markets through separate compliance paths produces duplicated costs, divergent documentation, and two separate exposures to audit failure. A device that holds a valid certificate and a complete registration in one market remains legally unsellable in the other until the second chain is closed. The weakest link governs both markets.
The constraint is not capital and it is not technology. It is architecture.
The Solution: A Unified Operating System
We do not build two systems. We design a single Quality Management System—ISO 13485—engineered to generate the evidence required by EU Notified Bodies and Swissmedic simultaneously.
- One system, two markets. The QMS is structured to withstand the conformity assessment of the EU Notified Body and, at the same time, to satisfy the Swiss requirements for swissdamed registration. One audit chain, two market doors.
- Synchronized vigilance. Post-market events are managed once, with outputs routed correctly to both EUDAMED and swissdamed, respecting their distinct timelines and formats.
- Eliminated redundancy. The client never maintains parallel systems. One source of truth produces every registration, every report, and every piece of evidence required by either jurisdiction.
Outcome
The result is not merely compliance. It is a single, robust operating infrastructure through which the Swiss and EU markets are accessed together—one investment, one audit readiness, one chain of evidence. Regulatory complexity is absorbed by the architecture and ceases to be a recurring tax on the business.